.webp/jcr:content.webp)
Vaccines
Support your patients with Vaccines
Guidelines for RSV prevention with Nirsevimab
Respiratory Syncytial Virus (RSV) is a major cause of lower respiratory tract infections in infants and young children. Nirsevimab is a long-acting monoclonal antibody that provides passive immunization against RSV, offering protection throughout the RSV season with a single dose
RSV Shield: WEQAYA's Strategy on Nirsevimab Implementation
This video explains WEQAYA's strategy on Nirsevimab Implementation
